Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 9INDUSTRY 5NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

Fluorouracil 3irinotecan sucrosofate 2Leucovorin 2zolbetuximab 1pembrolizumab 1beta-D-glucosylisophosphoramide mustard 1Drug Therapy 14-fluorobenzoyl-TN-14003 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Metastatic Pancreatic Adenocarcinoma × Clear all
NCT06396091 2025-11-13

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Astellas Pharma Inc

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT05078775 2025-07-18

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Faeth Therapeutics

Phase NA Completed
39 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT05383352 2025-04-30

SIRACUSA

Ipsen

Phase 1 Completed
177 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01954992 2024-12-31

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Eleison Pharmaceuticals LLC.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02826486 2024-08-28

COMBAT

BioLineRx, Ltd.

Phase 2 Completed
80 enrolled 13 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡